Creyos
- Company typePrivate
- Founded2014
- HeadquartersToronto, Canada
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
Creyos firmographics
Firmographics- Name
- Creyos
- Legal name
- Cambridge Brain Sciences Inc.
- Website
- https://creyos.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
Creyos industry classification
Industry- Product category
- Digital Cognitive Assessment Software
- NAICS
- Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182), Custom Computer Programming Services (541511)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Patient Relationship Management (PRM) & CRM for Provider Growth (Marketing/Outreach) (HLACAEAO)
Keywords
Where Creyos is headquartered
LocationHeadquarters
- HQ city
- Toronto
- HQ country
- Canada
- HQ region
- North America
Offices2 records
Markets served
Creyos business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Cognitive Assessment Platform Subscription: Creyos operates on a subscription basis providing access to its cognitive assessment platform, including cognitive tasks, behavioral questionnaires, protocols, and reporting. The platform is used by healthcare providers and can be reimbursed as part of Medicaid services and Medicare Annual Wellness Visits.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise/Healthcare Organization Pricing |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Creyos product offering
Product offeringCore offering
Creyos provides a digital cognitive assessment platform that delivers scientifically validated online cognitive tasks and standardized behavioral health questionnaires for healthcare providers. The platform includes 12 cognitive tasks measuring domains such as short-term memory, reasoning, concentration, and verbal ability, alongside condition-focused assessment protocols for ADHD and dementia, automated reporting, and direct EHR integration with Epic and Athenahealth. It is used by 10,000+ healthcare providers to evaluate brain health across conditions including dementia, ADHD, concussion, and traumatic brain injury.
Product overview
Creyos offers a digital cognitive assessment platform built on over 30 years of scientific research, consisting of a core platform with multiple integrated modules. The core platform provides 12 online cognitive tasks measuring specific brain functions (short-term memory, reasoning, concentration, verbal ability) and standardized behavioral health questionnaires. Supporting modules include condition-focused assessment protocols for ADHD and dementia, a rapid two-task digital cognitive screener for dementia detection, Care Planning for dementia management aligned to Alzheimer's Association guidelines, and automated reporting with EHR integration. The platform serves medical practices, health systems, payers, and researchers across neurology, psychiatry, occupational therapy, concussion/brain injury, primary care, and senior-focused care.
Differentiator
Problem solved
Functional benefit
Products and services
- Creyos Cognitive Assessment Platform Digital cognitive assessment platform providing scientifically-validated cognitive testing and behavioral health questionnaires for healthcare providers to evaluate brain health across conditions including dementia, ADHD, concussion, and traumatic brain injury.
- Online Cognitive Tasks Twelve computerized cognitive tests measuring specific cognitive domains including short-term memory (Number Ladder, Spatial Span, Paired Associates, Token Search), reasoning (Odd One Out, Spatial Planning, Rotations, Polygons), concentration (Double Trouble, Feature Match), and verbal ability (Digit Span, Grammatical Reasoning).
- Behavioral Health Questionnaires Digital standardized questionnaires covering mental health (PHQ-9, GAD-7, PSS, MDQ, PCL-5), ADHD and autism (SWAN, VADRS, ASRS Part A, AQ), substance misuse (AUDIT, ORT, DAST-10, PMQ), and brain injury/disturbances (RPQ, IADL, PSQI).
- Condition-Focused Assessment Protocols Pre-made, condition-specific cognitive assessment protocols including ADHD Assessment and Dementia Screening and Assessment, designed for timely clinical decision-making with pre-selected tasks and questionnaires.
- Dementia Screening and Assessment End-to-end solution for cognitive screening, assessment, and care including a rapid two-task screener (under 5 minutes), comprehensive 20-minute diagnostic assessment, care planning, and longitudinal monitoring for mild cognitive impairment and dementia.
- ADHD Assessment Protocol Scientifically-validated cognitive assessment protocol testing cognitive domains linked to ADHD, measuring performance against 14 specific ADHD markers with age-appropriate questionnaire options (ASRS Part A, SWAN, VADRS).
- Cognitive Reports Automated reporting system generating concise reports comparing patient performance against healthy norms, providing clear next steps and care planning guidance for healthcare providers.
- Care Planning Dementia care planning feature integrated into the platform, enabling primary care providers to create personalized care plans addressing medication, lifestyle changes, risk factors, and caregiver support, aligned to Alzheimer's Association guidelines.
Quantifiable outcome
- Two-task screener achieved 100% sensitivity and 86% specificity for Alzheimer's disease detection in approximately 6 minutes without clinical supervision
- +3 more outcomes
Companies that use Creyos
Customer profileNamed customers5 records
Segments6 records
Ideal customer profiles6 records
Creyos technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
AI capability3 records
Feature6 records
Creyos partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and major.
- Epic SystemscoreCreyos is expanding integration capabilities to directly connect with Epic EHR, embedding cognitive assessment workflows into the clinical environment. This enables cognitive insights to flow into everyday care within the most widely adopted EHR system used by 42% of large healthcare organizations.
- Western UniversitycoreResearchers at Western University conducted a peer-reviewed validation study published in the Journal of Alzheimer's Disease, demonstrating Creyos' digital screener achieves 100% sensitivity and 86% specificity for Alzheimer's detection. The study validates Creyos as a faster, more sensitive approach to dementia detection in primary care.
- AARPmajorAARP chose Cambridge Brain Sciences (now Creyos) to deliver their Staying Sharp Program, focused on cognitive health for older adults.
- AthenahealthcoreCreyos integrates with Athenahealth EHR for seamless cognitive care through automated reporting, results interpretation, and workflow integration.
Scale indicators5 records
Recent moves6 records
Creyos competitors and assessment
Company assessmentDirect peers
- Linus Health: Linus Health offers digital cognitive assessment (e.g., DCTclock, Linus Brain Health Platform) for early detection of Alzheimer's and other dementias, directly competing with Creyos in primary care dementia screening with similar EHR integration strategy.
- BrainCheck: BrainCheck provides digital cognitive assessment batteries and concussion screening tools used by clinicians across neurology, primary care, and sports medicine, overlapping directly with Creyos's 12-task battery and concussion clinic segments.
- Cambridge Cognition: Cambridge Cognition offers computerized cognitive testing (CANTAB) for clinical trials and healthcare, sharing scientific heritage with Creyos and competing in the same neurological/psychiatric assessment space.
- Cogstate: Cogstate provides digital cognitive assessment for clinical trials, healthcare, and concussion management, with comparable FDA-cleared tools and a similar customer base in pharma research and sports medicine.
- Neurotrack: Neurotrack develops digital cognitive screening and brain health tools for early Alzheimer's detection, directly competing with Creyos's two-task screener in the primary care and consumer brain-health segments.
- CNS Vital Signs: CNS Vital Signs provides computerized neurocognitive testing batteries for clinicians, researchers, and concussion programs, with comparable product offering and target segments to Creyos.
Emerging players
- Altoida: Altoida uses AI-driven digital cognitive assessment (including AR-based tasks) to predict and detect cognitive impairment, representing an emerging technology approach that overlaps with Creyos's machine-learning-based screener.
- Savonix: Savonix offers a digital cognitive assessment platform for clinicians and payers, with a similar mobile-first assessment model targeting dementia screening and behavioral health.
- Total Brain: Total Brain delivers web-based cognitive and emotional self-assessment tools for healthcare and consumer wellness, with overlapping mental health and brain-health screening use cases versus Creyos.
Broad incumbents
- Headspace Health (Ginger): Headspace Health (including the Ginger acquisition) offers broad mental health assessment and behavioral health screening at scale, partially overlapping with Creyos's behavioral health questionnaire suite in employer/payer channels.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Creyos social profiles
Digital presenceCreyos compliance and trust
Trust signalCompliance1 record
Creyos financial estimates
Financial estimateRevenue estimate
Valuation estimate
Creyos leadership team
Management profileNumber of profiles
Profiles12 records
Creyos funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Creyos M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Creyos
What does Creyos do?
Creyos provides a digital cognitive assessment platform that delivers scientifically validated online cognitive tasks and standardized behavioral health questionnaires for healthcare providers. The platform includes 12 cognitive tasks measuring domains such as short-term memory, reasoning, concentration, and verbal ability, alongside condition-focused assessment protocols for ADHD and dementia, automated reporting, and direct EHR integration with Epic and Athenahealth. It is used by 10,000+ healthcare providers to evaluate brain health across conditions including dementia, ADHD, concussion, and traumatic brain injury.
Is Creyos a public or private company?
Creyos is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Creyos founded?
Creyos was founded in 2014. It employs 51 to 100 people.
Where is Creyos based?
Creyos is headquartered in Toronto, Canada, in the North America region.
How does Creyos make money?
One revenue line is on record: cognitive Assessment Platform Subscription.
Who are Creyos's main competitors?
Direct peers on record are Linus Health, BrainCheck, Cambridge Cognition, Cogstate, Neurotrack and CNS Vital Signs. Emerging players are Altoida, Savonix and Total Brain. Headspace Health (Ginger) is listed as a broad incumbent.
Does Creyos have an API?
Yes. Creyos offers an API that enables cognitive assessment workflows to be embedded into clinical environments. The platform integrates with Epic EHR systems, allowing cognitive assessment data to flow directly into patient records within existing clinical workflows. Developer documentation is at cambridgebrainsciences.zendesk.com/hc/en-us.
What industry is Creyos in?
Creyos's product category is Digital Cognitive Assessment Software. Its primary akta.pro industry code is HLACAEAO, Patient Relationship Management (PRM) & CRM for Provider Growth (Marketing/Outreach). Its NAICS code is 5182 and its SIC code is 7372.